Abstract
Objectives
An observational study to compare the laminar distributions in frontal and temporal cortex of the tau-immunoreactive pathologies in chronic traumatic encephalopathy (CTE) and Alzheimer’s disease neuropathologic change (ADNC).
Patients
Post-mortem material of (1) four cases of CTE without ADNC, (2) seven cases of CTE with ADNC (CTE/ADNC), and (3) seven cases of ADNC alone.
Results
In CTE and CTE/ADNC, neurofibrillary tangles (NFT), neuropil threads (NT), and dot-like grains (DLG) were distributed either in upper cortex or across all layers. Low densities of astrocytic tangles (AT) and abnormally enlarged neurons (EN) were not localized to any specific layer. Surviving neurons exhibited peaks of density in both upper and lower cortex, and vacuole density was greatest in superficial layers. In ADNC, neuritic plaques (NP) were more frequent, AT rare, NFT and NT were more widely distributed, NT affected lower layers more frequently, and surviving neurons were less frequently bimodal than in CTE and CTE/ADNC.
Conclusion
Tau pathology in CTE and CTE/ADNC consistently affected the upper cortex but was more widely distributed in ADNC. The presence of CTE may encourage the development of ADNC pathology later in the course of the disease.
Keywords: Chronic traumatic encephalopathy (CTE), Alzheimer’s disease neuropathologic change (ADNC), Tauopathy, Laminar distribution
Introduction
Chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder associated with repetitive traumatic brain injury (TBI) [1]. Clinical symptoms include impairment of memory and executive function, behavioral change, and motor dysfunction [2]. Neuropathologically, there is reduced gray matter volume affecting the frontal and anterior temporal lobes [3, 4]. A spectrum of tau-immunoreactive pathology is present including neurofibrillary tangles (NFT) and neuropil threads (NT) [3], dot-like grains (DLG) [5], and astrocytic tangles (AT) [2, 6]. Low densities of abnormally enlarged neurons (EN) and vacuolation are also present [5]. By contrast, Alzheimer’s disease neuropathologic change (ADNC) is characterized by the presence of β-amyloid (Aβ) deposits in the form of neuritic plaques (NP) and tau-immunoreactive NFT without an extensive glial pathology [7, 8]. ADNC often occurs as a co-pathology with CTE but the relationship between CTE and ADNC remains controversial [7, 8]. To compare the two pathologies, an observational study of the changes in density of the NFT, NT, DLG, and AT together with EN, surviving neurons, and vacuoles was carried out across cortical regions in CTE alone, CTE with ADNC (CTE/ADNC), and ADNC alone.
Materials and methods
Cases
Cases were obtained from Boston University’s CTE center (VA-BU-CLF Brain Bank) (Table 1). With the exception of a boxer for 26 years (case A), all CTE cases had played American football (career durations 11–21 years). Patients had suffered at least one traumatic episode resulting in concussion, some with accompanying loss of consciousness, the majority experiencing multiple traumas. CTE diagnosis was according to criteria of McKee et al. [9] and cases were divided into two groups: (1) four cases of CTE without ADNC and (2) seven cases of CTE with ADNC (CTE/ADNC) with varying densities of β-amyloid (Aβ) deposits and NP [10] (CTE/ADNC). Seven cases of ADNC with no history of traumatic brain injury were also studied, six having a clinical diagnosis of Alzheimer’s disease (AD) and one of dementia/possible AD.
Table 1.
Case | Sex | Age* | Duration of dementia (years) | Trauma (years) | Career length (years) | A | B | C |
---|---|---|---|---|---|---|---|---|
CTE | ||||||||
A | M | 60 | 6 | 1/1 | 26 | 0 | 1 | 0 |
B | M | 70 | 8 | 3/0 | 21 | 0 | 1 | 0 |
C | M | 70 | 11 | 50/1 | 17 | 0 | 2 | 0 |
D | M | 70 | 26 | Fr | 20 | 0 | 2 | 0 |
CTE/ADNC | ||||||||
E | M | 75 | 10 | 10/2 | 18 | 3 | 2 | 1 |
F | M | 70 | 4 | 10/1 | 11 | 1 | 2 | 0 |
G | M | 65 | 10 | na | 19 | 2 | 2 | 1 |
H | M | 80 | 15 | F | 12 | 2 | 2 | 0 |
I | M | 80 | 40 | na | 18 | 3 | 2 | 1 |
J | M | 70 | 9 | 10/1 | 19 | 2 | 1 | 1 |
K | M | 60 | 8 | 25/1 | 21 | 3 | 2 | 0 |
ADNC | ||||||||
A | F | 90 | 5 | – | – | 3 | 2 | 1 |
B | M | 70 | 3 | – | – | 2 | 2 | 1 |
C | F | 80 | 5 | – | – | 2 | 1 | 0 |
D | F | 85 | 12 | – | – | 3 | 2 | 1 |
E | F | 90 | 9 | – | – | 2 | 1 | 1 |
F | M | 70 | 14 | – | – | 1 | 2 | 1 |
G | M | 70 | 8 | – | – | 3 | 2 | 1 |
ADNC Alzheimer’s disease neuropathologic change, M male, F female, Fr frequent, *Age rounded to nearest 5-year age interval to protect subject identities, na not available
Tissue preparation
The local Institute Review Board of Boston University approved the study and were carried out according to the 1995 Declaration of Helsinki (as modified in Edinburgh, 2000). Brains were fixed in 10% neutral buffered formalin for at least 2 weeks, paraffin-embedded, and sections cut at 6 μm. Blocks were taken from (1) frontal lobe to study the superior frontal gyrus (SFG) (BA 8,6), (2) temporal pole (BA 38,36), (3) temporal lobe to study the superior temporal gyrus (STG) (BA 22), and (4) medial temporal lobe to study the entorhinal cortex (EC) (BA 28). Immunohistochemistry was performed using antibodies against phosphorylated tau (AT8, Pierce Endogen, Rockford, IL, USA; 1:2000). Each slide was scanned and subsequently visualized on a PC using Aperio Image-Scope Software (Leica Biosystems Inc. Buffalo Grove, IL, USA).
Morphometric methods
The laminar distribution the histological features was studied using previously described methods [11]. Two traverses of 250 × 50-μm fields arranged contiguously and superimposed over the image from pia mater to white matter were located in each region, one along the upper side of the gyrus adjacent to the crest and the second at the deepest point of the sulcus. NFT, NT, DLG, NP, AT, EN, surviving neurons, and vacuoles were counted within each field along the traverse.
Data analysis
Changes in density of a histological feature with distance across the cortex were analyzed using a polynomial curve-fitting procedure to establish the curve of best fit (STATISTICA software, Statsoft Inc., 2300 East 14th St, Tulsa, OK, 74104, USA) [12]. Chi-square (χ2) contingency table tests were used to determine differences in cortical distribution among the three groups of cases.
Results
The curve fitting procedure is illustrated in Fig. 1 (Case F, CTE/ADNC, TP). The distributions of the NFT (r = 0.70, P < 0.01) and NT (r = 0.63, P < 0.01) were fitted by third-order polynomial curves with peaks of maximum density in the upper cortex. The distribution of the DLG was fitted by a fourth-order polynomial (r = 0.75, P < 0.01) suggesting a bimodal distribution with density peaks in upper and lower cortex, the upper peak being larger than the lower.
In the data as a whole (Table 2), AT were present largely in CTE and CTE/ADNC scattered across all layers. Conversely, NP were largely present in ADNC most frequently in the upper cortex. The distributions of the NFT (χ2 = 3.86, P > 0.05), NT (χ2 = 3.72, P > 0.05), and DLG (χ2 = 10.67, P > 0.05) were not significantly different in CTE and CTE/ADNC. However, there were differences in the NFT (χ2 = 15.34, P < 0.01), NT (χ2 = 28.06, P < 0.001), and DLG (χ2 = 12.15, P < 0.05) in CTE and CTE/ADNC compared with ADNC. In CTE and CTE/ADNC, the NFT, NT, and DLG were confined to the upper layers more frequently and NT to the lower layers less frequently than in ADNC. The surviving neurons were also more frequently bimodal in CTE and CTE/ADNC than ADNC. There were no differences in distribution of the EN or vacuolation in CTE, CTE/ADNC, and ADNC. Laminar changes were similar in gyri compared with the sulci and in case A (the boxer) compared with the other CTE cases representing ex footballers.
Table 2.
Laminar distribution | |||||||
---|---|---|---|---|---|---|---|
Cases | Pathology | U | L | U > L | U = L | U < L | NS |
CTE | NFT | 8 | 0 | 7 | 1 | 0 | 14 |
NT | 13 | 3 | 4 | 1 | 0 | 12 | |
DLG | 19 | 3 | 7 | 0 | 0 | 2 | |
AT | 3 | 1 | 0 | 0 | 0 | 5 | |
EN | 0 | 4 | 0 | 0 | 0 | 23 | |
SN | 7 | 0 | 10 | 3 | 1 | 10 | |
Vac | 16 | 0 | 2 | 4 | 2 | 8 | |
NP | 0 | 0 | 0 | 0 | 0 | 0 | |
CTE/ADNC | NFT | 20 | 1 | 5 | 2 | 0 | 26 |
NT | 19 | 2 | 7 | 2 | 3 | 14 | |
DLG | 25 | 0 | 16 | 5 | 1 | 7 | |
AT | 1 | 2 | 1 | 1 | 0 | 21 | |
EN | 2 | 10 | 0 | 2 | 0 | 38 | |
SN | 18 | 2 | 11 | 9 | 0 | 16 | |
Vac | 30 | 5 | 11 | 3 | 0 | 6 | |
NP | 0 | 0 | 0 | 0 | 0 | 6 | |
ADNC | NFT | 4 | 4 | 7 | 3 | 0 | 35 |
NT | 4 | 17 | 5 | 0 | 4 | 11 | |
DLG | 10 | 2 | 21 | 5 | 2 | 4 | |
AT | 0 | 1 | 2 | 0 | 1 | 0 | |
EN | 2 | 17 | 0 | 1 | 1 | 29 | |
SN | 19 | 1 | 3 | 5 | 1 | 24 | |
Vac | 32 | 3 | 6 | 1 | 0 | 11 | |
NP | 13 | 5 | 5 | 0 | 0 | 4 |
Comparison of frequencies (χ2 contingency tables). CTE compared with CTE/ADNC: NFT χ2 = 3.86 (4DF, P > 0.05), NT χ2 = 3.70 (5DF, P > 0.05), DLG χ2 = 10.67 (5DF, P > 0.05); AT χ2 = 6.44 (4DF, P > 0.05), EN χ2 = 2.61 (3DF, P > 0.05), SN χ2 = 5.55 (5DF, P > 0.05), Vac χ2 = 12.72 (5DF, P < 0.05); Totals for CTE compared with ADNC: NFT χ2 = 15.34 (4DF, P < 0.01), NT χ2 = 28.06 (5DF, P < 0.001), DLG χ2 = 12.15 (5DF, P < 0.05), AT χ2 = 18.70 (5DF, P > 0.01), EN χ2 = 1.41 (4DF, P > 0.05), SN χ2 = 16.12 (5DF, P < 0.01), Vac χ2 = 4.45 (6DF, P > 0.05)
Discussion
The data suggest the tau pathology of frontal and temporal lobes in CTE and CTE/ADNC affected upper cortical layers typical of the tauopathies [12, 13]. In addition, in some regions, the distribution of the tau pathology affected either both upper and lower cortex, or a more uniform distribution was present.
The distribution of the surviving neurons in CTE and CTE/ADNC was highly variable. In normal elderly brain, larger neuronal perikarya in frontal and temporal cortex peak in upper and lower cortex, the upper peak being larger than the lower. In CTE and CTE/ADNC, a similar distribution was observed in 21/87 regions, and in a further 12 regions, the densities were similar in upper and lower cortex suggesting loss of neurons in upper layers. In 25 regions, a single density peak was present in upper cortex suggesting loss of lower neurons and in a further 26 regions, there were no significant changes in neuronal density across the cortex indicating a more general loss of neurons across the cortex. Where a more localized distribution of EN was present, maximum density occurred in the lower layers similar to other tauopathies [12–14]. Vacuolation of the superficial layers was also a consistent finding in CTE and CTE/ADNC and in many gyri, the density of vacuoles decreased across the cortex.
Difference in the distribution of the pathology in CTE and CTE/ADNC compared with ADNC [14], suggested the tau pathology of CTE/ADNC was more restricted to the upper layers compared with ADNC. If CTE is the primary pathology, related to brain trauma, ADNC tau pathology may develop later in the disease remaining more or less confined to the upper cortical layers. If ADNC is the primary pathology, the tau pathology spreads earlier to affect more of the cortical layers than in CTE/ADNC. ADNC cases were older than the CTE and CTE/ADNC cases, a factor which could also have affected the laminar distributions in ADNC. ADNC cases also had a mixture of males and females unlike the CTE cases, which were exclusively male, but no differences have been observed in laminar distribution between males and females in several disorders [12, 13, 15]. The data also suggest that ADNC develops later in CTE, consistent with the hypothesis that repetitive brain injury also encourages the development of ADNC.
In conclusion, pathological changes in frontal and temporal lobes in CTE and CTE/ADNC most consistently affect upper cortical layers typical of the tauopathies. Lower layers can also be affected but usually to a lesser extent. In addition, there are differences in laminar distributions of the tau pathology in CTE with or without ADNC and ADNC alone consistent with the later development of ADNC in a subset of CTE cases.
Acknowledgments
The authors gratefully acknowledge the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA, USA) and the Chronic Traumatic Encephalopathy Program at Boston University School of Medicine, VA Boston and the Bedford VA.
Funding information
This work was supported by the National Institute of Neurological Disorders and Stroke (1UO1NS086659-01), Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS), Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C), the National Institute of Aging Boston University Alzheimer’s Disease Center (P30AG13846; supplement 0572063345–5), and the Charles F. and Joanne Knight Alzheimer’s Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA (P50 AG05681 and P01 AG03991).
Compliance with ethical standards
Ethical approval
These studies were approved by the local Institute Review Board of Boston University and were carried out according to the 1995 Declaration of Helsinki (as modified in Edinburgh, 2000).
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Jordan BD. The clinical spectrum of sport-related traumatic brain injury. Nat Rev Neural. 2013;9:222–230. doi: 10.1038/nrneurol.2013.33. [DOI] [PubMed] [Google Scholar]
- 2.Saing T, Dick M, Nelson PT, Kim RC, Cribbs DH, Head E. Frontal cortex neuropathology in dementia pugilistica. J Neurotrauma. 2012;29:1054–1070. doi: 10.1089/neu.2011.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.McKee AC, Stein TD, Nowinski CJ, Stern RA, Daneshvar DH, Alvarez VE, Lee HS, Hall G, Wojtowicz SM, Baugh CM, Riley DO, Kubilus CA, Cormier KA, Jacobs MA, Martin BR, Abraham CR, Ikezu T, Reichard RR, Wolozin BL, Budson AE, Goldstein LE, Kowall NW, Cantu RC. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136:43–64. doi: 10.1093/brain/aws307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.McKee AC, Daneshvar DH, Alvarez VE, Stein TD. The neuropathology of sport. Acta Neuropathol. 2014;127:29–51. doi: 10.1007/s00401-013-1230-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Armstrong RA, McKee AC, Stein TD, Alvarez VE, Cairns NJ. A quantitative study of tau pathology in 11 cases of chronic traumatic encephalopathy. Neuropathol Appl Neurobiol. 2016;43:154–166. doi: 10.1111/nan.12323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Stein TD, Alvarez VE, McKee AC. Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel. Alzheimers Res Ther. 2014;6:4. doi: 10.1186/alzrt234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Graham DI, Gentleman SM, Lynch A, Roberts GW. Distribution of beta-amyloid protein in the brain following severe head-injury. Neuropath Appl Neurobiol. 1995;21:27–34. doi: 10.1111/j.1365-2990.1995.tb01025.x. [DOI] [PubMed] [Google Scholar]
- 8.Stein TD, Montinegro PH, Alvarez VE, Xia W, Crary JF, Tripodis Y, Daneshvar DH, Mez J, Soloman T, Meng G, Kubilus CA, Cormier KA, Meng KA, Babcock K, Kiernan P, Murphy L, Nowiski CK, Martin B, Dixon D, Stern RA, Cantu RC, Kowall NW, McKee AC. Beta-amyloid deposition in chronic traumatic encephalopathy. Acta Neuropathol. 2015;130:21–34. doi: 10.1007/s00401-015-1435-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl D, Stein TD, Vonsattel JP, Stewart W, Tripodis Y, Crary JF, Bienick KF, Dams-O’Connor K, Alverez VF, Gordon WA, the TBI/CTE group The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016;131:75–86. doi: 10.1007/s00401-015-1515-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT, National Institute on Aging; Alzheimer’s Association National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol. 2012;23:1–11. doi: 10.1007/s00401-011-0910-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Duyckaerts C, Hauw JJ, Bastenaire F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Berthaux P. Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol. 1986;70:249–256. doi: 10.1007/BF00686079. [DOI] [PubMed] [Google Scholar]
- 12.Armstrong RA, Cairns NJ. Laminar distribution of the pathological changes in frontal and temporal cortex in eight patients with progressive supranuclear palsy. Clin Neuropathol. 2009;28:350–357. doi: 10.5414/NPP28046. [DOI] [PubMed] [Google Scholar]
- 13.Armstrong RA, Lantos PL, Cairns NJ. Laminar distribution of ballooned neurons and tau positive neurons with inclusions in patients with corticobasal degeneration. Neurosci Res Commun. 2000;27:85–93. doi: 10.1002/1520-6769(200009/10)27:2<85::AID-NRC1>3.0.CO;2-5. [DOI] [Google Scholar]
- 14.Hof PR, Bouras C, Buee L, Delacourte A, Perl DP, Morrison JH. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer’s disease cases. Acta Neuropathol. 1992;85:23–30. doi: 10.1007/BF00304630. [DOI] [PubMed] [Google Scholar]
- 15.Armstrong RA. Laminar distribution of frontal and temporal cortex in Parkinson’s disease dementia. Neurol Sci. 2017;38:667–671. doi: 10.1007/s10072-017-2828-6. [DOI] [PubMed] [Google Scholar]